In addition to the induction of IL-7 secretion, Ad-REIC facilitates an anti-tumorigenic microenvironment by promoting tumor-associated antigen-specific CD8+ cytotoxic T lymphocytes (CTLs) [9]. The gene discussed is IL7; the disease is neoplasm.